Clinical Trials Logo

Visual Snow Syndrome clinical trials

View clinical trials related to Visual Snow Syndrome.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05569733 Completed - Clinical trials for Visual Snow Syndrome

Simultaneous Fluorodeoxyglucose Positron Emission Tomography (PET) and Magnetic Resonance (MR) in Visual Snow Syndrome

Start date: January 2, 2017
Phase:
Study type: Observational

Visual snow syndrome (VSS) is a neurologic condition where patients experience tiny flickering dots in their entire visual field. It has been reported that the brain consumes more glucose in the lingual gyrus (a subdivision of the occipital cortex) and that this also shows increased volume of grey matter (neurons and supporting cells). In this study, the investigators apply fluor-18 fluorodeoxyglucose positron emission tomography with magnetic resonance imaging (18F-FDG PET/MR) in patients with VSS and compare this to healthy controls. Aside from an analysis in each brain volume element (voxel), the accuracy of classifying groups based on a volume-of-interest (VOI) analysis of both PET and MR is studied, Lastly, this is also compared to a visual assessment of the PET and MR images.

NCT ID: NCT04925232 Completed - Clinical trials for Visual Snow Syndrome

Transcranial Magnetic Stimulation For Visual Snow Syndrome

TMSVS
Start date: August 1, 2019
Phase: N/A
Study type: Interventional

This study aims to investigate the feasibility of the use of repetitive transcranial magnetic stimulation (rTMS) for symptoms associated with Visual Snow syndrome (VS).

NCT ID: NCT04184726 Completed - Photophobia Clinical Trials

Mindfulness Based Cognitive Therapy Modified for Visual Symptoms (MBCT-vision)

MBCT-vision
Start date: January 9, 2020
Phase: N/A
Study type: Interventional

This is a research study on Mindfulness-Based Cognitive Therapy for visual symptoms (MBCT-vision), to treat patients with debilitating symptoms of visual snow (VS) and is associated visual symptoms, severe light sensitivity (i.e. photophobia) and migrainous visual aura. Participants will receive an intervention of an 8-week MBCT course modified for visual symptoms, which will involve 8 weeks of once weekly group sessions and home practice between sessions.